Tharimmune (THAR) Form 3: President reports no beneficial ownership
Tharimmune, Inc. (THAR) filed a Form 3 initial statement of beneficial ownership.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Tharimmune, Inc. (THAR) filed a Form 3 initial statement of beneficial ownership. The reporting person is an officer serving as President, and the filing indicates no securities are beneficially owned as of the event date 11/06/2025.
This is a routine insider disclosure filed by one reporting person and does not reflect any purchases, sales, or holdings. The signature line is by Mark Toomey.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Tharimmune (THAR) file?
Who is the reporting person in THAR’s Form 3?
What is the event date on the THAR Form 3?
Does the reporting person own THAR securities?
Is this a joint filing for THAR?
What is Tharimmune’s ticker symbol?
AI-generated analysis. How Rhea-AI works. Not financial advice.